ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

UK Research Groups To Fund Virtual Tumor Bank

April 18, 2003

Organ Systems Move, Other Directory Changes

July 7, 1989

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Conference Level For NCI Is 5.4% Over FY 1990

November 2, 1990

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981